Open Access Articles

Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review

, 2017; 15(2): 81 - 85

Jesus Rodriguez-Pascual* and Antonio Cubillo




Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases

, 2015; 13(2): 93 - 98

Mohammed Akbar, Musthafa M. Essa, Byoung-Joon Song and Mohammed A.S. Khan




Systematic 3D Screening of Amino Acid Mutations in Pharmacogenes

, 2014; 12(4): 209 - 226

Thanawadee Preeprem and Greg Gibson




Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics

, 2013; 11(4): 312 - 315

Nicola L. Bragazzi




Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga

, 2013; 11(2): 98 - 109

Derek So and Yann Joly




Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine

, 2013; 11(2): 162 - 166

Nicola L. Bragazzi




Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem

, 2012; 10(4): 277 - 287

Y. W. Francis Lam




Teaching Pharmacogenetics in Low and Middle Income Countries (LMICs): An Empirical Study of the Lessons Learned

, 2012; 10(3): 217 - 225

Fatima Ghaddar, Karim Saba and Nathalie K. Zgheib




Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?

, 2012; 10(3): 182 - 184

Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu




A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation

, 2012; 10(3): 179 - 181

Bev J. Holmes




Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine

, 2011; 9(4): 299 - 322

Murielle Bochud, Michel Burnier and Idris Guessous




The Genetic Privacy Carousel: A Discourse on Proposed Genetic Privacy Bills and the Co-Evolution of Law and Science

, 2011; 9(4): 252 - 263

Edward S. Dove




Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation

, 2011; 9(3): 191 - 207

Louise Warnich, Britt I. Drogemoller, Michael S. Pepper, Collet Dandara and Galen E.B. Wright




Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines

, 2011; 9(3): 184 - 190

Anatasha Crawford and Rita Nahta




Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens

, 2009; 7(4): 263 - 274

R. Nahta, S. Shabaya, T. Ozbay and D. L. Rowe




Interview: Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health

, 2009; 7(3): 158 - 163

Muin J. Khoury




Functional Crosstalk Between β2-adrenoreceptor and Muscarinic Acetylcholine Receptor: Implications for Gene-Gene Interactions and Bronchodilatory Responses in Patients with Asthma and COPD

, 2008; 6(4): 302 - 319

Takahiro Yoshikawa and Hiroshi Kanazawa




Do Estrogen Receptor β Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?

, 2008; 6(4): 239 - 259

Stephanie L. Nott, Yanfang Huang, Brian R. Fluharty, Anna M. Sokolov, Melinda Huang, Cathleen Cox and Mesut Muyan




Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health

, 2008; 6(2): 108 - 120

Catherine Olivier, Bryn Williams-Jones, Beatrice Godard, Barbara Mikalson and Vural Ozdemir




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science